Head-to-Head: which drug eases unexplained pain better?

NCT ID NCT06803485

Recruiting now Symptom relief Sponsor: All India Institute of Medical Sciences, Bhubaneswar Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 28 times

Summary

This study compares two antidepressants, venlafaxine and dosulepin, to see which better reduces pain and improves daily life in people with somatic symptom disorder (SSD). SSD involves persistent physical complaints, often pain, linked to stress and brain chemistry. The trial will enroll 84 adults aged 18-65 who have not taken related medications recently, measuring symptom changes and stress-related biomarkers over 8 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOMATIC SYMPTOM DISORDER (DSM-V) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

All India Institute of Medical Sciences (AIIMS)
RECRUITING

Bhubaneswar, Odisha, 751019, India

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SOMATIC SYMPTOM DISORDER (DSM-V)